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1 0 Cytosolic and nuclear proteins were prepared from frozen kidney tissues as described previously (Das et al., 2010) . The kidney tissues were homogenized in an ice-cold 10 mM TrisHCl buffer (pH 8.0) containing 0.32 M sucrose, 3 mM calcium chloride (CaCl 2 ), 2 mM magnesium acetate (MgOAc), 0.1 mM EDTA, 0.5% nonidet P-40 (NP-40), 1 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM orthovanadate and 30 mM sodium fluoride (NaF) and 10 µg/ml of leupeptin and aprotinin. The homogenate was centrifuged at 8000 × g at 4 °C for 20 min and the supernatant was separated and stored as a cytosolic fraction. The pellet was washed in 3 x wash buffer (same as above except NP-40) by resuspending with a 20 gauge needle and centrifugation at 6000 × g. The pellet was resuspended in a low-salt buffer (20 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 20 mM KCl, 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT, and 0.5 mM PMSF), incubated on ice for 5 min, and mixed with an equal volume of high-salt buffer containing 20 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 800 mM KCl, 0.2 mM EDTA, 1% NP-40, 25% glycerol, 0.5 mM DTT, 0.5 mM PMSF, 1 mM orthovanadate and 30 mM NaF and 10 µg/ml of leupeptin and aprotinin. The mixture was incubated on ice for 30 min and centrifuged at 14,000 × g for 20 min. The supernatant was separated and stored as a nuclear fraction at -80 °C.
Western blot assay
Cytoplasmic fraction (40-60 µg) or nuclear extract (30-50 μ g) was mixed with sample loading buffer and separated by using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) essentially as described earlier (Das et al., 2010) . Proteins were electrotransferred onto a polyvinylidene difluoride (PVDF) membrane and the membrane was blocked with 1x Tris-buffered saline-Tween 20 (TBST; 25 mM Tris, 500 mM NaCl, and 0.05%
Tween 20, pH 7.5) containing 5% fat-free milk for 1 h and incubated overnight in TBST containing 3% fat-free milk at 4 °C with primary antibodies (1:250 dilution). The membrane 
Plasma Membrane Preparation and Guanylyl Cyclase Activity Assay
The plasma membranes from kidney tissues were prepared as described previously (Khurana and Pandey, 1996) . Briefly, kidney tissues were homogenized in 5 volumes of 10 mM sodium phosphate buffer (pH 7.4) containing 250 mM sucrose, 150 mM NaCl, 1 mM PMSF, 5 mM benzamidine, 5 mM EDTA, and 10 μ g/ml each of leupeptin and aprotinin, centrifuged at 400 × g for 10 min at 4 °C, and the supernatant collected was recentrifuged at 80,000 × g for 1 h at 4 °C. The resultant supernatant was discarded, and the pellet was resuspended in 1 ml of 50 mM HEPES buffer (pH 7.4) containing 150 mM NaCl, 1 mM PMSF, 5 mM benzamidine, 5 mM EDTA, and 10 μ g/ml each of leupeptin and aprotinin and centrifuged at 80,000 × g for 1 h at 4 °C. The final pellet was suspended in 200 μ l of HEPES buffer (pH 7.4). GC activity was assayed as described by Leitman et al. (Leitman et al., 1988) with modifications (Khurana and Pandey, 1996) . A 50 μ g aliquot of plasma membrane was added to 100 μ l of GC assay buffer containing 50 mM Tris-Cl buffer (pH 7.6), 4 mM MnCl 2 , 2 mM 3-isobutyl-1-methylxanthine, 1 mM BSA, 5 units creatinine phosphokinase, 7.5 mM creatine phosphate, and 0.5 mM GTP. The samples were incubated in a water bath at 37 °C for indicated time. Reaction was stopped by adding 900 μ l of 55 mM sodium acetate (pH 6.2), and sample tubes were placed in boiling water bath for 5 min and then on ice for 15 min to stop the reaction. Samples were centrifuged at 13,000 × g for 5
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1 2 min, supernatant was collected, and the generated cGMP was determined using a direct cGMP immunoassay kit.
cGMP assay
Frozen kidney tissue samples were homogenized in 10 vol of 0.1 M HCl containing 1%
Triton X-100. The homogenate was centrifuged at 10,000 rpm at 4 °C, and the supernatant was collected and used for cGMP assay. MMCs were treated with TTNPB and ATRA-NaBu for 24 h and stimulated with ANP at 37 °C for 15 min in the presence of 0.2 mM 3-isobutyl-1-methylxanthine, washed three times with PBS, and scraped into 0.5 N HCl. Cell suspension was subjected to five-cycles of freeze and thaw. The mixture was centrifuged at 10,000 rpm for 15 min. The supernatant thus collected was used for the cGMP assay. Cyclic GMP levels were determined using a direct cGMP immunoassay kit according to the manufacturer's protocol. The results are expressed as picomoles of cGMP/mg of protein.
HDAC and HAT activity assay
Total HDAC and HAT enzyme activities were measured in drug-treated and control kidney nuclear extracts using colorimetric ELISA assay kit from Active motif (Carlsbad, CA) and Epigentek (Farmingdale, NY), respectively. The HDAC activity was calculated by measuring the amount of HDAC-deacetylated product, which was directly proportional to the HDAC enzyme activity. For the HAT enzyme activity assay the amount of acetylated product was measured.
Absorbance was read at 450 nm and results were calculated using a standard curve following manufacturer's instructions and expressed as ng/h/mg protein.
Quantitative Chromatin Immunoprecipitation Assay
Chromatin was prepared from frozen kidney tissue samples and ChIP was performed using
ChIP-IT Express kit (Active Motif). Tissue samples were weighed, finely minced on ice, and 25
mg of tissue for each IP was used. Tissue was transferred to a 2 ml tube containing PBS and protease inhibitor cocktail and 37% formaldehyde (final concentration 1.5%) was added with rocking at room temperature for 20 min to crosslink protein to DNA. Cross-linking was stopped by adding 100 μ l of 10 x glycine, mixed for 5 min, and centrifuged at 1,500 rpm for 5 min at 4 °C. Pellet was washed with PBS, centrifuged at 1,500 rpm at 4 °C, and resuspended in PBS containing protease inhibitors. Pellet was disaggregated using Dounce's homogenizer, centrifuged at 1,500 rpm at 4 °C, and was used for nuclei preparation and chromatin digestion.
The pellet was resuspended in 1 ml of digestion buffer and 50 μ l of enzymatic shearing mixture and incubated at 37 °C for 10 min. The reaction was stopped by adding 20 μ l of 0.5 M EDTA followed by chilling on ice for 10 min. Sheared DNA was centrifuged at 13,000 rpm at 4 °C for 10 min and supernatant was collected. Ten percent of supernatant was saved as input DNA and processed for further use as positive control. Immunoprecipitation was performed using protein G magnetic beads and 5 μ g of antibodies of H3-K9/14ac, H4-K12ac, H3-K4-me3, H3-K9me3, PCAF, and p300 or control IgG at 4 °C with overnight rotation. Beads were pelleted and washed sequentially once with ChIP-buffer 1 and twice with ChIP-buffer 2. After washing the magnetic beads, bound protein was eluted by gentle rotation for 25 min in elution buffer at 22 °C. Crosslinking of the protein/DNA complex was reversed at 65 °C overnight to release DNA.
Immunoprecipitated DNA was sequentially treated with RNase A and proteinase K and then purified. The Npr1 proximal promoter region containing Ets-1 and Sp1 transcription factor binding sites was PCR amplified using purified DNA as a template and the forward (5'-gaggggaggattcgctgc-3') and reverse (5'-ctaagaagagcgaggggagc-3') primers. The antibodies used in ChIP assay are listed in (Supplemental Table 1 ). For quantitative ChIP assay, real-time PCR MOL # 92221
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was performed with RT 2 real-time™ SYBR Green/ROX PCR Master Mix (SABiosciences).
Real-time RT-PCR Assay
Total RNA was extracted using RNeasy plus mini-kit (Qiagen). Thirty mg of kidney tissue was used to extract RNA. First-strand cDNA was synthesized from 1 μ g of total RNA in a final volume 20 μ l using RT 2 First Strand kit (SABiosciences). Primers for Npr1 and β-actin were purchased from SABiosciences. The Ets-1 gene was amplified using forward (5'-atcagctggacaggagattgc -3') and reverse (5'-cgcgtatacgtaggcgttgc-3') primers. Real-time RT-PCR was performed using the Mx3000P real-time PCR system and data were analyzed with MxPro software (Stratagene, La Jolla, CA). The reaction mixture without template cDNA was used as a negative control. The Npr1 and Ets-1 expression values were normalized to β -actin.
Relative expression of the Npr1 and Ets-1 gene was determined by the comparative Ct value.
Immunohistochemistry of proliferating cell nuclear antigen (PCNA) and α -smooth muscle actin (α-SMA)
Immunohistochemical staining for PCNA and α -SMA proteins was done on 5 µm sections of paraffin-embedded kidney tissues as previously described (Das et al., 2010) . Briefly, after dewaxing in xylene, the kidney sections were dehydrated by serial dilutions of alcohol (100%, 90%, and 70%) for 10 min each and washed in PBS for 5 min. Sections were incubated in 0.3% to the Npr1 promoter in kidneys of ATRA-and Nabu-treated 1-copy, 2-copy, and 3-copy mice.
Values are expressed as mean ± SE of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001 (vehicle-treated versus drug-treated same group); # p < 0.05, ## p < 0.01 (1-copy or 3-copy versus 2-copy); n=7 mice per group. analysis of renal protein levels of PCAF and p300 in Npr1 1-copy, 2-copy, and 3-copy mice treated with ATRA and NaBu. TBP was used as loading control. Quantitative ChIP assay demonstrating in vivo recruitment of (E) PCAF and (F) p300 to the Npr1 promoter in ATRAand NaBu-treated and vehicle-treated mice. Bar represents mean ± SE. WB represents Western blot; * p < 0.05; ** p < 0.01, *** p < 0.001; (vehicle-treated versus drug-treated same group); # p < 0.05, ## p < 0.01(1-copy or 3-copy versus 2-copy); n=6 mice per group. 
